Dr.reddy's Laboratories Ltd — Ertapenem Exporter Profile
Indian Pharmaceutical Exporter · #4 for Ertapenem · $1.8M export value · DGFT Verified
Dr.reddy's Laboratories Ltd is the #4 Indian exporter of Ertapenem with $1.8M in export value and 35 verified shipments. Dr.reddy's Laboratories Ltd holds a 4.5% market share in Ertapenem exports across 2 countries.
Dr.reddy's Laboratories Ltd — Ertapenem Export Profile: Buyers & Destinations
Where Does Dr.reddy's Laboratories Ltd Export Ertapenem?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.1M | 23 | 67.6% |
| CANADA | $550.0K | 12 | 32.4% |
Dr.reddy's Laboratories Ltd exports Ertapenem to 2 countries. The largest destination is UNITED STATES accounting for 67.6% of Dr.reddy's Laboratories Ltd's Ertapenem shipments. These destinations reflect Dr.reddy's Laboratories Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ertapenem from Dr.reddy's Laboratories Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NORTHSTAR DISTRIBUTION CENTRE 8912 | UNITED STATES | $650.0K | 13 |
| DR. REDDYS LABORATORIES, INC | UNITED STATES | $350.0K | 7 |
| DR REDDYS LABORATORIES CANADA INC | CANADA | $200.0K | 4 |
| TO THE ORDER OF* . | CANADA | $150.0K | 3 |
| NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $100.0K | 2 |
| DR.REDDYS LABORATORIES CANADA INC | CANADA | $100.0K | 2 |
| DR.REDDY S LABORATORIES CANADA INC | CANADA | $50.0K | 1 |
| DR. REDDYS LABORATORIES CANADA INC | CANADA | $50.0K | 1 |
| NORTHSTAR DISTRIBUTION CE | UNITED STATES | $50.0K | 1 |
| DELPHARM | CANADA | $49 | 1 |
Dr.reddy's Laboratories Ltd supplies Ertapenem to 10 buyers globally. The largest buyer is NORTHSTAR DISTRIBUTION CENTRE 8912 (UNITED STATES), followed by DR. REDDYS LABORATORIES, INC (UNITED STATES) and DR REDDYS LABORATORIES CANADA INC (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ertapenem Export Value and How Much Does Dr.reddy's Laboratories Ltd Contribute?
India exported $35.1M worth of Ertapenem through 780 shipments from 54 suppliers to 46 countries, serving 137 buyers globally. Dr.reddy's Laboratories Ltd contributes $1.8M to this total, accounting for 4.5% of India's Ertapenem exports. Dr.reddy's Laboratories Ltd ships Ertapenem to 2 countries through 10 buyers.
What Is the Average Shipment Value for Dr.reddy's Laboratories Ltd's Ertapenem Exports?
Dr.reddy's Laboratories Ltd's average Ertapenem shipment value is $50.0K per consignment, based on 35 shipments totaling $1.8M. The largest destination is UNITED STATES (67.6% of Dr.reddy's Laboratories Ltd's Ertapenem exports).
How Does Dr.reddy's Laboratories Ltd Compare to Other Indian Ertapenem Exporters?
Dr.reddy's Laboratories Ltd ranks #4 among 54 Indian Ertapenem exporters with a 4.5% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($26.9M), DR.REDDY'S LABORATORIES LTD ($1.8M), GLAND PHARMA LIMITED ($1.4M). Dr.reddy's Laboratories Ltd processed 35 shipments to 2 destination countries.
What Ertapenem Formulations Does Dr.reddy's Laboratories Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ERTAPENEM FOR INJECTION 1G/VIAL - 10 S ( | $300.0K | 6 |
| ERTAPENEM FOR INJ IG/VIAL 10S CA | $150.0K | 3 |
| ERTAPENEM FOR INJ IG/VIAL 10S CA (963 X | $100.0K | 2 |
| ERTAPENEM FOR INJ.1G/VIAL CA (2890 X 10 | $50.0K | 1 |
| ERTAPENEM FOR INJ. 1G/VIAL 10S NS (968 X | $50.0K | 1 |
| ERTAPENEM FOR INJ. 1G/VIAL 10S NS (971 X | $50.0K | 1 |
| ERTAPENEM FOR INJ. 1G/VIAL 10S NS (962 X | $50.0K | 1 |
| ERTAPENEM FOR INJ. 1G/VIAL 10S NS (959 X | $50.0K | 1 |
| ERTAPENEM FOR INJ 1G/VIAL 10S CA (978X10S=9780 NOS) | $50.0K | 1 |
| ERTAPENEM FOR INJ. 1G/VIAL 10'S NS (980X 10'S PACKS = 9800 NOS)NOS | $50.0K | 1 |
Dr.reddy's Laboratories Ltd exports 27 distinct Ertapenem formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ERTAPENEM FOR INJECTION 1G/VIAL - 10 S ( with 6 shipments worth $300.0K.
Regulatory Requirements: Exporting Ertapenem to Key Markets
What Dr.reddy's Laboratories Ltd must comply with to export Ertapenem to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Dr.reddy's Laboratories Ltd Compare to Nearest Ertapenem Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED | $26.9M | 537 | 11 | $50.0K |
| 4 | DR.REDDY'S LABORATORIES LTD ★ | $1.8M | 35 | 2 | $50.0K |
| 3 | GLAND PHARMA LIMITED | $1.4M | 29 | 4 | $50.0K |
| 8 | UNITED BIOTECH PRIVATE LIMITED | $1.3M | 29 | 9 | $44.1K |
Dr.reddy's Laboratories Ltd ranks #4 among 54 Indian Ertapenem exporters. Average shipment value of $50.0K compared to the market average of $649.6K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and GLAND PHARMA LIMITED.
Which Indian Ports Ship Ertapenem Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 248 | 31.8% |
| DELHI AIR | 185 | 23.7% |
| Delhi Air | 71 | 9.1% |
| HYDERABAD ACC (INHYD4) | 52 | 6.7% |
| HYDERABAD AIR | 33 | 4.2% |
| PETRAPOLE | 23 | 2.9% |
| SAHAR AIR | 21 | 2.7% |
| Dadri CGML | 19 | 2.4% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ertapenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ertapenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Dr.reddy's Laboratories Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 35 individual customs records matching Dr.reddy's Laboratories Ltd exporting Ertapenem, covering 27 formulations to 2 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 46+ countries, 137+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ertapenem Export Data from Dr.reddy's Laboratories Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dr.reddy's Laboratories Ltd's Ertapenem exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Dr.reddy's Laboratories Ltd
Company Profile
0 products · $0 total trade · 0 categories
Ertapenem Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Dr.reddy's Laboratories Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ertapenem. For current shipment-level data, contact TransData Nexus.